[Protective effects of rosiglitazone on hepatotoxicity in hepatocytes cultured with cyclosporine A].
Liu
Zhang-suo
ZS
Department of Nephrology, First Hospital, Zhengzhou University, Zhengzhou 450052, China. zhangsuoliu@sina.com
Cheng
Gen-yang
GY
Li
Hai-jian
HJ
Liu
Shu-zhen
SZ
Yao
Li-na
LN
Li
Ji-chang
JC
D000818:Animals; D002478:Cells, Cultured; D016572:Cyclosporine / Q000037:antagonists & inhibitors*; D005353:Fibronectins / Q000096:biosynthesis / Q000235:genetics; D022781:Hepatocytes / Q000166:cytology* / Q000187:drug effects; D047495:PPAR gamma / Q000096:biosynthesis / Q000235:genetics; D020011:Protective Agents / Q000494:pharmacology*; D012333:RNA, Messenger / Q000096:biosynthesis / Q000235:genetics; D051381:Rats; D000077154:Rosiglitazone; D045162:Thiazolidinediones / Q000494:pharmacology*; D053773:Transforming Growth Factor beta1 / Q000096:biosynthesis / Q000235:genetics
D005353:Fibronectins; D047495:PPAR gamma; D020011:Protective Agents; D012333:RNA, Messenger; D045162:Thiazolidinediones; D053773:Transforming Growth Factor beta1; D000077154:Rosiglitazone; D016572:Cyclosporine